iShares Biotechnology ETFIBB
IBB
0
Funds holding %
of 7,372 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
10% more funds holding in top 10
Funds holding in top 10: 10 [Q3] → 11 (+1) [Q4]
2% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 113
3% less funds holding
Funds holding: 879 [Q3] → 852 (-27) [Q4]
4.46% less ownership
Funds ownership: 67.18% [Q3] → 62.73% (-4.46%) [Q4]
12% less capital invested
Capital invested by funds: $5.24B [Q3] → $4.58B (-$654M) [Q4]
34% less repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 315
49% less call options, than puts
Call options by funds: $424M | Put options by funds: $829M
Research analyst outlook
We haven’t received any recent analyst ratings for IBB.
Financial journalist opinion
Positive
Seeking Alpha
1 week ago
Invest In A New Biotech Bull Market With XBI And IBB
Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides more leverage to the biotech turnaround trade. Falling interest rates, weak GDP growth, low inflation, and Fed rate cuts mean the macro environment is ripe for biotech.
Neutral
Seeking Alpha
2 weeks ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Neutral
Zacks Investment Research
1 month ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Positive
See It Market
1 month ago
Stock Market Rotation: To Healthcare (XLV), Then Biotechnology (IBB)
Here are some of the recent references I have made about Biotechnology Sector (IBB) and the potential for a rally. Incidentally, Moderna (MRNA) is so oversold on a monthly timeframe, it should be on your radar.
Neutral
CNBC Television
1 month ago
How tariffs could impact pharma and early-stage healthcare investments
Carl Rizzuto, Versant Ventures managing director, joins 'Fast Money' to talk the impact of tariffs on healthcare.
Positive
ETF Trends
1 month ago
Can Health Care ETFs Aid Your Portfolio?
The Health Care Select Sector SPDR ETF (XLV) was up approximately 6% year-to-date as of January 29. While it is still early days, this performance is already twice as robust as the sector ETF's performance for all of 2024.
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the iShares Biotechnology ETF (IBB)?
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
Negative
Yahoo Finance
1 month ago
Biotech walks a 'tightrope' amid unclear funding, regulations
Earlier this week, the Trump administration froze and then rescinded the freeze on federal funding for several programs, including research funding that the biotech industry relies on. Clear Street senior equity analyst and director of research, Mara Goldstein, sits down with Julie Hyman and Josh Lipton on Market Domination to discuss how to play the biotech sector as Trump's second term in the White House is underway.
Negative
24/7 Wall Street
1 month ago
I Was Convinced Biotech Stocks Were Too Risky—This Innovation's Changing the Game
The biotech scene can be seen as fairly risky for new investors who want to put money to work.
Neutral
See It Market
1 month ago
Important Stock Market ETFs Begin January Trend Trade
For today's market update, I am giving you a peek at our all-important list of stock market ETFs and where they all sit relative to this significant trading range reset. If you are unfamiliar with the January Calendar range, the Outlook 2025, link further below, covers a brief description.
Charts implemented using Lightweight Charts™